Clinical Trial Update: Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating adjuvant chemotherapy and immunotherapy after complete surgical resection in small cell lung cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: Small Cell Lung Cancer (SCLC) | Phase 2 | Status: RECRUITING